Journal
JOURNAL OF FUNCTIONAL FOODS
Volume 18, Issue -, Pages 631-642Publisher
ELSEVIER
DOI: 10.1016/j.jff.2015.08.026
Keywords
Isatis indigotica; Arabinogalactan; Adjuvant; Vaccine; TNF-alpha
Categories
Funding
- New Drug Creation Manufacturing Program [2012ZX09301001-003]
- Twelfth Five Years National Sciences and Technology Support Plan Project [2011BAD26B02-3]
Ask authors/readers for more resources
Isatis indigotica is an important medical herb in China and has been used for treating influenza and epidemic hepatitis for hundreds of years in China. in this study, an arabinogalactan (IIP-2) was firstly isolated from root of Isatis indigotica. Its chemical structure was identified and its adjuvant activity was investigated in mice co-immunised with H1N1 influenza vaccine or hepatitis B surface antigen (HBsAg). The results revealed that IIP-2 has a molecular weight of 66,400 Da and is composed of arabinose and galactose at a ratio of 1.0:1.5. Its structure contained a beta-(1 -> 3, 6)-galacan backbone. Pharmacological data demonstrated that IIP-2 could increase antigen-specific antibody levels in immunised mice. IIP-2-adjuvanted influenza or HBsAg vaccines improved proliferation of splenocytes and macrophages, stimulate cytokine productions. IIP-2 itself cannot show effects listed above. These results suggested that IIP2-adjuvanted vaccines enhanced humoral and cellular immunity. IIP-2 could be developed as an efficacious adjuvant in human and animal vaccines. (C) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available